A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Irritable Bowel Syndrome (IBS), Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 10/13/2018 |
| Start Date: | August 2007 |
| End Date: | June 2019 |
| Contact: | Jessica Lim |
| Email: | jessica.lim@ucsf.edu |
| Phone: | 415-885-3734 |
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with
Inflammatory Bowel Disease study is being conducted at the University of California San
Francisco and 30 other sites around the United States who are part of the CCFA Clinical
Alliance. The aim of this study is to determine the effect of medication use and disease
activity on the outcome of pregnancy among women with IBD up to 15 years from birth.
Inflammatory Bowel Disease study is being conducted at the University of California San
Francisco and 30 other sites around the United States who are part of the CCFA Clinical
Alliance. The aim of this study is to determine the effect of medication use and disease
activity on the outcome of pregnancy among women with IBD up to 15 years from birth.
All pregnant women with IBD diagnosis who are taking biologics medicines and
immunosuppressants will be entered in the study.
immunosuppressants will be entered in the study.
Inclusion Criteria:
- Female patients with confirmed IBD diagnoses who are pregnant and taking
immunosuppressants and/or biologic therapy
Exclusion Criteria:
- Pregnant female patients younger than 18 years of age
- Confirmed multiple gestation
We found this trial at
2
sites
San Francisco, California 94143
Principal Investigator: Uma Mahadevan, MD
Phone: 415-885-3734
Click here to add this to my saved trials
San Francisco, California 94115
Click here to add this to my saved trials